Published in: 2nd International Personalized Medical Congress
COI code: IPMCMED02_192
Paper Language: English
How to Download This Paper
For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.
Authors Early Detection of Breast Cancer using a Panel of Circulating miRNAhanieh sadeghi - Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
Bahareh shayestepour - Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
arian kamal - Clinical Bioinformatics, Saarland University, University Hospital Saarbrücken, Germany
andreas keller - Clinical Bioinformatics, Saarland University, University Hospital Saarbrücken, Germany
Abstract:Breast cancer (BC) is the most common type of cancer in women which leads to more than 500,000 deaths, annually. This type of cancer is a heterogeneous disease with diverse traits and sub-types reflected by various clinical outcomes. Therefore, identification of biomarkers that can accurately detect BC is a crucial step for early diagnosis of BC and choosing the optimal treatment for it. Circulating microRNAs have presented great potential as promising tools for BC detection. In this regard, we previously discovered a novel panel of circulating microRNAs based on the expression profiling analysis of 6017 patients with 14 cancer types including BC. Data from the cancer genome atlas (TCGA) database crossed with three large blood-based miRNome datasets from 5351 patients, resulted in identification of a list of microRNAs. Six out of nine microRNAs were subsequently validated in whole blood using qRT-PCR in a pilot study on 70 BC patients and a control group. The expression level of candidate microRNAs was higher in whole blood samples collected from patients with BC compared to controls. Notably, our panel successfully differentiated fibrocystic types from healthy individuals in a pilot study. These results demonstrated the potential of this promising combination of microRNAs for detection of BC at its earlier stages in clinical settings.
Keywords:Breast Cancer, Early Detection, Circulating miRNA, Liquid Biopsy
COI code: IPMCMED02_192
how to cite to this paper:If you want to refer to this article in your research, you can easily use the following in the resources and references section:
sadeghi, hanieh; Bahareh shayestepour; arian kamal & andreas keller, 2017, Early Detection of Breast Cancer using a Panel of Circulating miRNA, 2nd International Personalized Medical Congress, تهران, دانشگاه علوم پزشكي بقيه الله(عج), https://www.civilica.com/Paper-IPMCMED02-IPMCMED02_192.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (sadeghi, hanieh; Bahareh shayestepour; arian kamal & andreas keller, 2017)
Second and more: (sadeghi; shayestepour; kamal & keller, 2017)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)
The University/Research Center Information:
Type: Research Center
Paper No.: 5268
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.
Research Info Management
Export Citation info of this paper to research management softwares
New Related Papers
The Above articles are recently indexed in the related subjects
Iran Scientific Advertisment Netword
Share this paper
WHAT IS COI?
COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.